Detailed Information on Publication Record
2012
Dementia Diagnosis and Treatment in Czech Neurological and Psychiatric Practices
SHEARDOVÁ, K., J. HORT, Irena REKTOROVÁ, R. RUSINA, V. LÍNEK et. al.Basic information
Original name
Dementia Diagnosis and Treatment in Czech Neurological and Psychiatric Practices
Name in Czech
Diagnostika a léčba demence českými neurology a psychiatry
Authors
SHEARDOVÁ, K. (203 Czech Republic), J. HORT (203 Czech Republic), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), R. RUSINA (203 Czech Republic), V. LÍNEK (203 Czech Republic) and A. BARTOŠ (203 Czech Republic)
Edition
Česká a slovenská neurologie a neurochirurgie, Praha, Česká lékařská společnost J.E.Purkyně, 2012, 1210-7859
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 0.372
RIV identification code
RIV/00216224:14110/12:00068877
Organization unit
Faculty of Medicine
UT WoS
000303294000011
Keywords in English
Alzheimer's disease; dementia; management; cholinesterase inhibitors; Czech Republic
Tags
International impact, Reviewed
Změněno: 22/7/2013 15:02, Ing. Mgr. Věra Pospíšilíková
Abstract
V originále
The aim of the study: The aim of this study was to obtain comprehensive information about standard practice in management of dementia among specialists responsible for the care of patients with cognitive deterioration in the Czech Republic. Methods: The data were collected by the means of structured questionnaires completed by neurologists, psychiatrists and geriatricians during seminars focused on cognitive topics. Results: 152 specialists were participating in the study. The respondents saw the mean of 27 patients with cognitive deficit monthly, 33% of whom suffer from Alzheimer disease. Neurologists diagnosed equal proportions of patients with mild cognitive impairment, and with mild to moderate stages of dementia; psychiatrists and geriatricians mostly diagnose patients at the moderate stage of the disease. Nearly all of the neurologists and half of the psychiatrists examined their patients by MRI or CT prior to starting therapy. SPECT was mainly used by neurologists (42%). The majority of patients took cholinesterase inhibitor (ChEI) for 2-3 years. Half of the specialists occasionally used dual therapy with ChEI and memantine. Nootropics were administered more frequently by psychiatrists. All the respondents prescribed an Selective Serotonin Reuptake Inhibitors (SSRI) for the therapy of coinciding depression. Conclusion: Dementia was managed by the majority of specialists according to the EFNS guidelines. The early stages of the disease were mostly handled by neurologists, who also tend to employ more sophisticated diagnostic tools in differential diagnosis of dementia.